Mvk Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 7.63 Cr
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
About Mvk Lifesciences
Mvk Lifesciences Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 October 2021 (Three years and three months 7 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.63 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gajanana Kudva and Kajal Damania serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51397MH2021PTC369982
- Company No.
369982
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Oct 2021
- Date of AGM
31 Dec 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Mvk Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gajanana Kudva  | Director | 01-Feb-2022 | Current |
| Kajal Damania | Director | 01-Feb-2022 | Current |
Financial Performance of Mvk Lifesciences.
Mvk Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mvk Lifesciences?
In 2022, Mvk Lifesciences had a promoter holding of 99.20% and a public holding of 0.80%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Noma Infrastructure Private LimitedKajal Damania is a mutual person
Apex Drugs LimitedGajanana Kudva and Kajal Damania are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mvk Lifesciences?
Mvk Lifesciences has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mvk Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mvk Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
